Company: INMB
Filing Date: 2025-07-25
Form Type: 8-K
Source: 0001213900-25-067791
Chunk: 0

Company: Inmune Bio, Inc.
Filing Date: 2025-07-25
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01. Other Events.

On July 24, 2025, INmune
Bio Inc. issued a press release announcing that additional analyses from its Phase 2 MINDFuL trial evaluating XPro™, a novel selective
soluble tumor necrosis factor inhibitor, will be released in an oral presentation at the Alzheimer’s Association International Conference
in Toronto, Canada on Tuesday, July 29, 2025, between 2:00 and 3:30 PM ET.

A copy of the press release
is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial statements and Exhibits